GPR55 (Serbian Wikipedia)

Analysis of information sources in references of the Wikipedia article "GPR55" in Serbian language version.

refsWebsite

Global rank Serbian rank

13nih.gov

4^th place

8^th place

12doi.org

2^nd place

4^th place

2archive.org

6^th place

5^th place

archive.org

Johns DG, Behm DJ, Walker DJ, Ao Z, Shapland EM, Daniels DA, Riddick M, Dowell S, Staton PC, Green P, Shabon U, Bao W, Aiyar N, Yue TL, Brown AJ, Morrison AD, Douglas SA (2007). „The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects”. Br. J. Pharmacol. 152 (5): 825—31. PMC 2190033 . PMID 17704827. doi:10.1038/sj.bjp.0707419.
Ryberg E, Larsson N, Sjögren S, Hjorth S, Hermansson NO, Leonova J, Elebring T, Nilsson K, Drmota T, Greasley PJ (2007). „The orphan receptor GPR55 is a novel cannabinoid receptor”. Br. J. Pharmacol. 152 (7): 1092—101. PMC 2095107 . PMID 17876302. doi:10.1038/sj.bjp.0707460.

doi.org

Brown AJ. (2007). „Novel cannabinoid receptors.”. Br J Pharmacol. 152 (5): 567—575. PMC 2190013 . PMID 17906678. doi:10.1038/sj.bjp.0707481.
McHugh D, Hu SS, Rimmerman N, Juknat A, Vogil Z, Walker JM, Bradshaw HB (2010). „N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor”. BMC Neuroscience. 11 (1): 44. PMC 2865488 . PMID 20346144. doi:10.1186/1471-2202-11-44.
Sawzdargo M, Nguyen T, Lee DK, Lynch KR, Cheng R, Heng HH, George SR, O'Dowd BF (1999). „Identification and cloning of three novel human G protein-coupled receptor genes GPR52, PsiGPR53 and GPR55: GPR55 is extensively expressed in human brain”. Brain Res. Mol. Brain Res. 64 (2): 193—8. PMID 9931487. doi:10.1016/S0169-328X(98)00277-0.
Baker D, Pryce G, Davies WL, Hiley CR (2006). „In silico patent searching reveals a new cannabinoid receptor”. Trends Pharmacol. Sci. 27 (1): 1—4. PMID 16318877. doi:10.1016/j.tips.2005.11.003.
Johns DG, Behm DJ, Walker DJ, Ao Z, Shapland EM, Daniels DA, Riddick M, Dowell S, Staton PC, Green P, Shabon U, Bao W, Aiyar N, Yue TL, Brown AJ, Morrison AD, Douglas SA (2007). „The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects”. Br. J. Pharmacol. 152 (5): 825—31. PMC 2190033 . PMID 17704827. doi:10.1038/sj.bjp.0707419.
Lauckner JE, Jensen JB, Chen HY, Lu HC, Hille B, Mackie K (2008). „GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current”. Proc. Natl. Acad. Sci. U.S.A. 105 (7): 2699—704. PMC 2268199 . PMID 18263732. doi:10.1073/pnas.0711278105.
Ryberg E, Larsson N, Sjögren S, Hjorth S, Hermansson NO, Leonova J, Elebring T, Nilsson K, Drmota T, Greasley PJ (2007). „The orphan receptor GPR55 is a novel cannabinoid receptor”. Br. J. Pharmacol. 152 (7): 1092—101. PMC 2095107 . PMID 17876302. doi:10.1038/sj.bjp.0707460.
Oka S, Nakajima K, Yamashita A, Kishimoto S, Sugiura T (2007). „Identification of GPR55 as a lysophosphatidylinositol receptor”. Biochemical and Biophysical Research Communications. 362 (4): 928—34. PMID 17765871. doi:10.1016/j.bbrc.2007.08.078.
Henstridge CM, Balenga NA, Ford LA, Ross RA, Waldhoer M, Irving AJ (2009). „The GPR55 ligand L-alpha-lysophosphatidylinositol promotes RhoA-dependent Ca2+ signaling and NFAT activation”. The FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology. 23 (1): 183—93. PMID 18757503. doi:10.1096/fj.08-108670.
Oka S, Toshida T, Maruyama K, Nakajima K, Yamashita A, Sugiura T (2009). „2-Arachidonoyl-sn-glycero-3-phosphoinositol: a possible natural ligand for GPR55”. Journal of Biochemistry. 145 (1): 13—20. PMID 18845565. doi:10.1093/jb/mvn136.
Staton PC, Hatcher JP, Walker DJ, Morrison AD, Shapland EM, Hughes JP, Chong E, Mander PK, Green PJ, Billinton A, Fulleylove M, Lancaster HC, Smith JC, Bailey LT, Wise A, Brown AJ, Richardson JC, Chessell IP (2008). „The putative cannabinoid receptor GPR55 plays a role in mechanical hyperalgesia associated with inflammatory and neuropathic pain”. Pain. 139 (1): 225—36. PMID 18502582. doi:10.1016/j.pain.2008.04.006.
Kress M, Kuner R (2009). „Mode of action of cannabinoids on nociceptive nerve endings”. Experimental Brain Research. Experimentelle Hirnforschung. Experimentation Cerebrale. 196 (1): 79—88. PMID 19306092. doi:10.1007/s00221-009-1762-0.

nih.gov

ncbi.nlm.nih.gov

„Entrez Gene: GPR55 G protein-coupled receptor 55”.
Brown AJ. (2007). „Novel cannabinoid receptors.”. Br J Pharmacol. 152 (5): 567—575. PMC 2190013 . PMID 17906678. doi:10.1038/sj.bjp.0707481.
McHugh D, Hu SS, Rimmerman N, Juknat A, Vogil Z, Walker JM, Bradshaw HB (2010). „N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor”. BMC Neuroscience. 11 (1): 44. PMC 2865488 . PMID 20346144. doi:10.1186/1471-2202-11-44.
Sawzdargo M, Nguyen T, Lee DK, Lynch KR, Cheng R, Heng HH, George SR, O'Dowd BF (1999). „Identification and cloning of three novel human G protein-coupled receptor genes GPR52, PsiGPR53 and GPR55: GPR55 is extensively expressed in human brain”. Brain Res. Mol. Brain Res. 64 (2): 193—8. PMID 9931487. doi:10.1016/S0169-328X(98)00277-0.
Baker D, Pryce G, Davies WL, Hiley CR (2006). „In silico patent searching reveals a new cannabinoid receptor”. Trends Pharmacol. Sci. 27 (1): 1—4. PMID 16318877. doi:10.1016/j.tips.2005.11.003.
Johns DG, Behm DJ, Walker DJ, Ao Z, Shapland EM, Daniels DA, Riddick M, Dowell S, Staton PC, Green P, Shabon U, Bao W, Aiyar N, Yue TL, Brown AJ, Morrison AD, Douglas SA (2007). „The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects”. Br. J. Pharmacol. 152 (5): 825—31. PMC 2190033 . PMID 17704827. doi:10.1038/sj.bjp.0707419.
Lauckner JE, Jensen JB, Chen HY, Lu HC, Hille B, Mackie K (2008). „GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current”. Proc. Natl. Acad. Sci. U.S.A. 105 (7): 2699—704. PMC 2268199 . PMID 18263732. doi:10.1073/pnas.0711278105.
Ryberg E, Larsson N, Sjögren S, Hjorth S, Hermansson NO, Leonova J, Elebring T, Nilsson K, Drmota T, Greasley PJ (2007). „The orphan receptor GPR55 is a novel cannabinoid receptor”. Br. J. Pharmacol. 152 (7): 1092—101. PMC 2095107 . PMID 17876302. doi:10.1038/sj.bjp.0707460.
Oka S, Nakajima K, Yamashita A, Kishimoto S, Sugiura T (2007). „Identification of GPR55 as a lysophosphatidylinositol receptor”. Biochemical and Biophysical Research Communications. 362 (4): 928—34. PMID 17765871. doi:10.1016/j.bbrc.2007.08.078.
Henstridge CM, Balenga NA, Ford LA, Ross RA, Waldhoer M, Irving AJ (2009). „The GPR55 ligand L-alpha-lysophosphatidylinositol promotes RhoA-dependent Ca2+ signaling and NFAT activation”. The FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology. 23 (1): 183—93. PMID 18757503. doi:10.1096/fj.08-108670.
Oka S, Toshida T, Maruyama K, Nakajima K, Yamashita A, Sugiura T (2009). „2-Arachidonoyl-sn-glycero-3-phosphoinositol: a possible natural ligand for GPR55”. Journal of Biochemistry. 145 (1): 13—20. PMID 18845565. doi:10.1093/jb/mvn136.
Staton PC, Hatcher JP, Walker DJ, Morrison AD, Shapland EM, Hughes JP, Chong E, Mander PK, Green PJ, Billinton A, Fulleylove M, Lancaster HC, Smith JC, Bailey LT, Wise A, Brown AJ, Richardson JC, Chessell IP (2008). „The putative cannabinoid receptor GPR55 plays a role in mechanical hyperalgesia associated with inflammatory and neuropathic pain”. Pain. 139 (1): 225—36. PMID 18502582. doi:10.1016/j.pain.2008.04.006.
Kress M, Kuner R (2009). „Mode of action of cannabinoids on nociceptive nerve endings”. Experimental Brain Research. Experimentelle Hirnforschung. Experimentation Cerebrale. 196 (1): 79—88. PMID 19306092. doi:10.1007/s00221-009-1762-0.